Patients with vs without central sensitization syndrome had significantly more severe autonomic and sensory symptoms.

Roughly 1 in 10 United States internal medicine physicians report a high degree of burnout, according to study findings.

Topline data were announced from 2 phase 3 trials evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.

Despite medical innovations, maternal mortality rates in the US remain high, especially compared with those of similarly ...

The Food and Drug Administration has granted Fast Track designation to urcosimod for the treatment of neuropathic corneal pain.

Chronic migraine with or without aura was significantly associated with an increased risk for PPD, particularly in women with psychiatric and obstetric comorbidities.

The head of the US FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.

Adults with chronic multisite pain had poorer psychosocial outcomes than those with single-site pain, but kinesiophobia levels were high in both groups.

HealthDay News — The Trump administration has canceled more than $800 million in research focused on LGBTQ health, cutting hundreds of studies on cancer, HIV and other diseases that affect sexual and ...

A new initiative called "Generation Gold Standard" was announced to develop next-generation, universal vaccines using a beta-propiolactone-inactivated, whole-virus platform.